Quick Answer
ACCENDRA HEALTH INC/VA/ reported Total Revenue of $2.76 billion for the year ending 2025.
- ACCENDRA HEALTH INC/VA/ showed an increase of +3.1% in Total Revenue from 2024 to 2025.
- This data is from ACCENDRA HEALTH INC/VA/'s annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $2.33 billion | Q1 2018: $2.37 billion | Q2 2018: $2.46 billion | Q3 2018: $2.46 billion | Q1 2019: $2.35 billion | Q2 2019: $2.38 billion | Q3 2019: $2.29 billion | Q1 2020: $2.12 billion | Q2 2020: $1.81 billion | Q3 2020: $2.19 billion | Q1 2021: $2.33 billion | Q2 2021: $2.49 billion | Q3 2021: $2.50 billion | Q1 2022: $2.41 billion | Q2 2022: $2.50 billion | Q3 2022: $2.50 billion | Q1 2023: $2.52 billion | Q2 2023: $2.56 billion | Q3 2023: $2.59 billion | Q1 2024: $2.61 billion | Q2 2024: $660.40 million | Q3 2024: $686.85 million | Q1 2025: $2.63 billion | Q2 2025: $681.92 million | Q3 2025: $697.26 million.
- Over the full 10 years of available data (2016 to 2025), ACCENDRA HEALTH INC/VA/'s Total Revenue has declined by 71.6%.
- Historical annual values: Fiscal year 2025: $2.76 billion | Fiscal year 2024: $2.68 billion | Fiscal year 2023: $2.55 billion | Fiscal year 2022: $9.96 billion | Fiscal year 2021: $9.79 billion | Fiscal year 2020: $8.48 billion | Fiscal year 2019: $9.21 billion | Fiscal year 2018: $9.42 billion | Fiscal year 2017: $9.32 billion | Fiscal year 2016: $9.72 billion.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: